TY - JOUR
T1 - Differentiation of human endometrial stem cells encapsulated in alginate hydrogel into oocyte-like cells
AU - Ghasemi, Diba
AU - Ebrahimi-Barough, Somayeh
AU - Nekoofar, Mohammad Hossein
AU - Mohamadnia, Abdolreza
AU - Lotfibakhshaiesh, Nasrin
AU - Bahrami, Naghmeh
AU - Karimi, Roya
AU - Nooshabadi, Vajihe Taghdiri
AU - Azami, Mahmoud
AU - Hasanzadeh, Elham
AU - Ai, Jafar
N1 - Publisher Copyright:
© 2023 The Author(s).
PY - 2023/5
Y1 - 2023/5
N2 - Introduction: Human endometrial mesenchymal stem cells (hEnMSCs) are a rich source of mesenchymal stem cells (MSCs) with multi-lineage differentiation potential, making them an intriguing tool in regenerative medicine, particularly for the treatment of reproductive and infertility issues. The specific process of germline cell-derived stem cell differentiation remains unknown, the aim is to study novel ways to achieve an effective differentiation method that produces adequate and functioning human gamete cells. Methods: We adjusted the optimum retinoic acid (RA) concentration for enhancement of germ cell-derived hEnSCs generation in 2D cell culture after 7 days in this study. Subsequently, we developed a suitable oocyte-like cell induction media including RA and bone morphogenetic protein 4 (BMP4), and studied their effects on oocyte-like cell differentiation in 2D and 3D cell culture media utilizing cells encapsulated in alginate hydrogel. Results: Our results from microscopy analysis, real-time PCR, and immunofluorescence tests revealed that 10 μM RA concentration was the optimal dose for inducing germ-like cells after 7 days. We examined the alginate hydrogel structural characteristics and integrity by rheology analysis and SEM microscope. We also demonstrated encapsulated cell viability and adhesion in the manufactured hydrogel. We propose that in 3D cell cultures in alginate hydrogel, an induction medium containing 10 μM RA and 50 ng/mL BMP4 can enhance hEnSC differentiation into oocyte-like cells. Conclusion: The production of oocyte-like cells using 3D alginate hydrogel may be viable in vitro approach for replacing gonad tissues and cells.
AB - Introduction: Human endometrial mesenchymal stem cells (hEnMSCs) are a rich source of mesenchymal stem cells (MSCs) with multi-lineage differentiation potential, making them an intriguing tool in regenerative medicine, particularly for the treatment of reproductive and infertility issues. The specific process of germline cell-derived stem cell differentiation remains unknown, the aim is to study novel ways to achieve an effective differentiation method that produces adequate and functioning human gamete cells. Methods: We adjusted the optimum retinoic acid (RA) concentration for enhancement of germ cell-derived hEnSCs generation in 2D cell culture after 7 days in this study. Subsequently, we developed a suitable oocyte-like cell induction media including RA and bone morphogenetic protein 4 (BMP4), and studied their effects on oocyte-like cell differentiation in 2D and 3D cell culture media utilizing cells encapsulated in alginate hydrogel. Results: Our results from microscopy analysis, real-time PCR, and immunofluorescence tests revealed that 10 μM RA concentration was the optimal dose for inducing germ-like cells after 7 days. We examined the alginate hydrogel structural characteristics and integrity by rheology analysis and SEM microscope. We also demonstrated encapsulated cell viability and adhesion in the manufactured hydrogel. We propose that in 3D cell cultures in alginate hydrogel, an induction medium containing 10 μM RA and 50 ng/mL BMP4 can enhance hEnSC differentiation into oocyte-like cells. Conclusion: The production of oocyte-like cells using 3D alginate hydrogel may be viable in vitro approach for replacing gonad tissues and cells.
KW - BMP4
KW - Differentiation
KW - hEnSCs
KW - Oocyte-like cells differentiation
KW - Retinoic acid
KW - Stem cell
UR - http://www.scopus.com/inward/record.url?scp=85170553171&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85170553171&partnerID=8YFLogxK
U2 - 10.34172/bi.2022.23960
DO - 10.34172/bi.2022.23960
M3 - Article
AN - SCOPUS:85170553171
SN - 2228-5652
VL - 13
SP - 229
EP - 240
JO - BioImpacts
JF - BioImpacts
IS - 3
ER -